Registry for patients referred to cardio-oncology
Official title: Cardio-Oncologie: étude Pilote évaluant la faisabilité, Utilité Concrète, Interdisciplinaire d'Une Unité Spécialisée
Run by European Georges Pompidou Hospital · NCT04407780 · Data updated 2026-11-12
This study is collecting information from cancer patients who are referred for heart health checks to see how cancer treatments might affect their hearts.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | European Georges Pompidou Hospital Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | January 1, 2017 |
| Main results expected | June 1, 2022 |
| Study ends | June 1, 2027 |
| Registry record updated | May 29, 2020 |
| Trial ID | NCT04407780 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are patients who have been referred for cardio-oncology assessment due to their cancer treatment.
✕Probably not a fit
Patients who refuse to participate in the registry will not benefit from the data collection and insights generated.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry aims to gather data on patients referred for cardio-oncology assessment, focusing on the intersection of cancer and heart health. By collecting prospective data, the study seeks to provide a clearer understanding of cardiotoxicity associated with cancer treatments and to identify early signals of heart-related issues in cancer patients. The registry will also support ancillary projects targeting specific cancer types and treatment regimens. The goal is to enhance the knowledge base in the emerging field of cardio-oncology.
Why it matters
Potential benefit: If successful, this registry could lead to improved monitoring and management of heart health in cancer patients, potentially reducing the risk of cardiotoxicity.
How similar studies have gone: While the field of cardio-oncology is emerging, similar registries have shown promise in enhancing understanding of the relationship between cancer treatments and cardiovascular health.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * referred to cardio-oncology Exclusion Criteria: * refusal to participate
Where it's running
-
Assistance Publique Hôpitaux de Paris - Centre Université de Paris
Paris, France Recruiting
Study contacts
- Study coordinator: Mariana Mirabel, MD, PhD
- Email: mariana.mirabel@aphp.fr
- Phone: +33156095636
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding health trends in Puerto Rico
This study is trying to understand health trends in Puerto Rico by looking at diet, mental health, and heart health in adults aged 30-75 over time.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Low-Calorie Diet in adolescents with Familial Mediterranean Fever and metabolic syndrome
A group of adolescents with both FMF and metabolic syndrome will try a low-calorie diet for 3 months to see if it helps manage metabolic symptoms.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.